In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants.
Chapters
00:00 Episode Preview
00:55 Introduction to BioTalk Unzipped
02:06 Charity Spotlight: Light of the World
04:51 Nathan Teuscher's Career Journey
07:34 Differentiating AI Types in Life Science
12:41 Challenges with Large Language Models
15:39 Rethinking Reporting in Pharma
17:56 The Future of AI and Analytics in Pharma?
18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies
23:05 Leveraging Data, AI, and APIs in 3 Dimensions
26:22 NEW NEWS! - Gene Editing Breakthroughs in Medicine
How to reach us:
Light the World Charity - Church of Jesus Christ Latter Day Saints
https://www.churchofjesuschrist.org/comeuntochrist/light-the-world
Nathan Teuscher
https://www.linkedin.com/in/nathanteuscher/
Aplos Analytics - https://aplosanalytics.com/
Nathan Teuscher’s Podcast: Clinical Pharmacology Podcast
https://teuschersolutions.com/
Collaboration with BioTalk Unzipped (Ep. 40)
Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/
Celerion - https://www.celerion.com/
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/
ECI - https://eci-rx.com /
Sound Bites
"We don't need to write reports anymore."
Takeaways
